Clinical Trials Logo

Filter by:
NCT ID: NCT05755282 Not yet recruiting - Hand Hygiene Clinical Trials

Touch and Feel Evaluation of Two Foam Hand Sanitizers

Start date: April 6, 2023
Phase: Phase 4
Study type: Interventional

Hand sanitizers are a standard of hygiene requirements. Hand sanitizers must be effective at reducing germ count on the hands while ideally providing emollients to moisturize the skin after use. To improve compliance with hand sanitizing protocols, hand sanitizers should provide a pleasant touch and feel experience for end users, especially for healthcare worker (HCW) users, who use these products frequently.

NCT ID: NCT05792384 Not yet recruiting - Clinical trials for Lung Transplant Rejection

Study of Transbronchial Cryobiopsy in Monitoring Complications of Lung Transplantation

Start date: April 6, 2023
Phase: N/A
Study type: Interventional

The goal of this randomized controlled trial is to compare the diagnostic efficacy and safety of transbronchial cryobiopsy (TBCB) and traditional transbronchial lung biopsy for diagnosing the lung transplantation rejection , so as to establish the evidence-based medical basis for the effectiveness and safety of TBCB for monitoring after lung transplantation, It is expected to provide a better auxiliary examination method for lung transplantation. The main questions it aims to answer are: (1) Histopathological evaluability of specimens; (2) Safety of TBCB; (3) Size and quality of specimen, and number of attempts to obtain five samples. Participants will undergo TBCB with 1.1 mm flexible cryoprobe or traditional transbronchial lung biopsy with biopsy forceps.

NCT ID: NCT06318442 Not yet recruiting - Clinical trials for Steroid-Induced Diabetes

The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes

Start date: April 6, 2024
Phase: N/A
Study type: Interventional

TITLE: How GLP-1 Analogues prevent steroid-induced diabetes (The GAPSID Study) DESIGN: A double-blind study evaluating how GLP-1 analogues, compared with metformin, prevent hyperglycaemia in response to a 7-day course of dexamethasone (DEX) 6 mg once daily. This is a mechanistic experimental medicine study. AIMS: To evaluate the mechanisms by which GLP-1 analogues reduce steroid-induced hyperglycaemia compared to metformin. OUTCOME MEASURES: - Primary: Glucose tolerance in response to standardised mixed meal test (MMT) lasting for 240 minutes, measured in all participants at baseline and on day 7 DEX. - Secondary: Indices of insulin resistance (M-value), beta-cell function (acute insulin response to glucose) and disposition, as measured by a combined IV glucose tolerance test and hyperinsulinaemic-euglycaemic clamp, performed at baseline and on day 7 DEX. - Exploratory: Tissue specific changes in adipose AMPK determined from adipose and muscle biopsies, taken from a subset of approximately 8 individuals in each group. ELIGIBILITY: People living with pre-diabetes or lifestyle controlled diabetes STUDY DURATION: This study will take place over 3 weeks for each partcipant. Study procedures include 10 days of baseline continuous glucose monitoring (CGM) followed by 7 days of dexamethasone with GLP-1, metformin or placebo. Participants will attend a follow-up visit 3-5 days after completing the 7-day course of study drug. The study will run over a period of 3 years. ANTICIPATED IMPACT: Mechanistic evidence for the use of GLP-1 analogues, compared with metformin, in the treatment of steroid-induced diabetes.

NCT ID: NCT06344091 Not yet recruiting - Clinical trials for Local Analgesia Via Infiltration

A Study of Bupivacaine Liposome Injection in Local Analgesia of Pediatric Patients

Start date: April 6, 2024
Phase: Phase 4
Study type: Interventional

The study is being conducted to evaluate the safety and efficacy of bupivacaine liposome injection for local infiltration analgesia in pediatric orthopedic surgery in the real world.

NCT ID: NCT04326881 Not yet recruiting - Pharmacokinetic Clinical Trials

A Study to Compare Pharmacokinetic and Safety Profiles of Different Formulations of SHR-1314 After Subcutaneous Injection in Healthy Subjects

Start date: April 7, 2020
Phase: Phase 1
Study type: Interventional

This study will be a single-center, randomized, parallel, open-label, single dosing bridging study in healthy subjects to evaluate the pharmacokinetics and safety of two formulations of SHR-1314.

NCT ID: NCT05805332 Not yet recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Evaluation of Skeletal Muscle Function Using Ultrasonic Elastography

Start date: April 7, 2023
Phase:
Study type: Observational

The goal of observational study is to evaluation of skeletal muscle function in patients with chronic obstructive pulmonary disease before and after lung rehabilitation training using ultrasonic elastography in Chronic Obstructive Pulmonary Disease. The main question it aims to answer are:Evaluation of skeletal muscle function in patients with chronic obstructive pulmonary disease before and after lung rehabilitation training using ultrasonic elastography. Participants will undergo pulmonary rehabilitation.

NCT ID: NCT06331026 Not yet recruiting - Clinical trials for Pediatric Growth Hormone Deficiency (PGHD)

A Bioequivalence Study of Two Different PEG-rhGH Preparations.

Start date: April 7, 2024
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate whether PEG-rhGH with new preparation is bioequivalent to PEG-rhGH with present preparation.

NCT ID: NCT06344611 Not yet recruiting - Clinical trials for Decompensated Cirrhosis

Incidence & Predictive Factors of Recompensation in Children With Decompensated Cirrhosis as Per the Baveno VII Criteria

Start date: April 7, 2024
Phase:
Study type: Observational

Cirrhosis is a leading cause of morbidity and mortality world- wide and can develop on the basis of repetitive and/or chronic liver injury due to toxic, infectious, metabolic and genetic pathogenic factors. Traditionally, the natural history of cirrhosis has often been considered a one-way street, with a definite and irreversible progression from a compensated to a decompensated disease stage. But recent data has shown that if the underlying etiology can be successfully treated, cirrhosis can regress and recompensation of liver disease can occur. Hence, in this study we want to evaluate the incidence and predictive factors of recompensation in pediatric subjects with decompensated cirrhosis as per the Baveno VII criteria. We would also evaluate the predictive factors of recompensation in pediatric decompensated chronic liver disase (DCLD) subjects and would explore systemic and intestinal inflammatory markers as possible biomarkers for predicting recompensation in pediatric subjects with decompensated cirrhosis.

NCT ID: NCT06347692 Not yet recruiting - Knee Osteoarthritis Clinical Trials

Effect of Antigravity Treadmill in Knee Osteoarthritis (AGTreadmill)

AGTreadmill
Start date: April 7, 2024
Phase: N/A
Study type: Interventional

To date, the anti-gravity treadmill, as a representative method of lower body positive pressure treadmills, has been rarely reported for knee osteoarthritis rehabilitation. Purpose: This study aims to evaluate the effect of antigravity treadmill training on pain, gait characteristics, and function in patients with knee osteoarthritis.

NCT ID: NCT05093972 Not yet recruiting - Clinical trials for Hepatic Insufficiency

Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014)

Start date: April 7, 2025
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate pharmacokinetics (PK) and safety of a single oral dose of ulonivirine in participants with mild or moderate hepatic impairment (HI). It is hypothesized that the area under the plasma concentration-time curve from dosing to (extrapolated) infinity (AUC0-∞) in participants with mild or moderate HI is similar to that of healthy control participants.